Genpact (G) Stock Price, News & Analysis

Company Overview

Genpact is a global professional services firm specializing in digitally powered business process management and services. The company partners with clients across industries to design, transform and run key operations, leveraging data analytics, artificial intelligence, automation and domain expertise. Its offerings span finance and accounting, supply chain management, procurement, customer experience, risk and compliance, and other critical business functions.

Founded in 1997 as the business process outsourcing arm of General Electric and originally known as GE Capital International Services, the company rebranded as Genpact in 2005 and completed its initial public offering on the New York Stock Exchange in 2007 under the ticker symbol “G.” Over time, Genpact has expanded beyond traditional outsourcing to focus on digital transformation and innovation, helping organizations accelerate growth and improve operational efficiency.

Headquartered in New York City, Genpact serves clients in more than 30 countries across North America, Latin America, Europe and Asia Pacific. The firm maintains delivery centers and innovation hubs in key markets, integrating local talent with global capabilities to support multinational corporations and regional enterprises alike. Its platform-based approach brings together digital technologies, industry knowledge and consulting expertise to address complex business challenges.

Since February 2011, Tiger Tyagarajan has served as president and chief executive officer, guiding Genpact’s evolution from a traditional outsourcing provider to a strategic digital partner. Under his leadership, the company has invested in advanced analytics, machine learning and robotic process automation, positioning itself as a leader in the emerging field of intelligent operations.

Key Stats

• Today's Range: $41.19 to $42.05
• 50-Day Range: $41.32 to $45.89
• 52-Week Range: $37.82 to $56.76
• Volume: 1.24 million shs
• Average Volume: 1.63 million shs
• Market Capitalization: $7.20 billion
• P/E Ratio: 13.73
• Dividend Yield: 1.65%
• Price Target: $52.29
• Consensus Rating: Hold

Genpact Stock Analysis - MarketRank™

Genpact scored higher than 89% of companies evaluated by MarketBeat, and ranked 126th out of 667 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.0 / 5
• Analyst Rating: Hold

Consensus Rating

Genpact has received a consensus rating of Hold. The company's average rating score is 2.43, and is based on 3 buy ratings, 4 hold ratings, and no sell ratings.

Upside Potential

Genpact has a consensus price target of $52.29, representing about 25.6% upside from its current price of $41.63.

Amount of Analyst Coverage

Genpact has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 8.72%

Earnings Growth

Earnings for Genpact are expected to grow by 8.72% in the coming year, from $3.21 to $3.49 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Genpact is 13.83, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 281.53.

Price to Earnings Ratio vs. Sector

The P/E ratio of Genpact is 13.83, which means that it is trading at a less expensive P/E ratio than the Computer and Technology sector average P/E ratio of about 452.85.

Price to Earnings Growth Ratio

Genpact has a PEG Ratio of 1.42. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Genpact has a P/B Ratio of 3.07. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

4.34% of the float of Genpact has been sold short.

Short Interest Ratio / Days to Cover

Genpact has a short interest ratio ("days to cover") of 4.1.

Change versus previous month

Short interest in Genpact has recently increased by 0.87%, indicating that investor sentiment is decreasing.

Dividend

• Score: 3.3 / 5
• Dividend Strength: Strong

Dividend Yield

Genpact pays a meaningful dividend of 1.65%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Genpact has been increasing its dividend for 6 years.

Dividend Coverage

The dividend payout ratio of Genpact is 22.59%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Genpact will have a dividend payout ratio of 19.48% next year. This indicates that Genpact will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

4.34% of the float of Genpact has been sold short.

Short Interest Ratio / Days to Cover

Genpact has a short interest ratio ("days to cover") of 4.1.

Change versus previous month

Short interest in Genpact has recently increased by 0.87%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 3.3 / 5
• News Sentiment: 0.87

News Sentiment

Genpact has a news sentiment score of 0.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.73 average news sentiment score of Computer and Technology companies.

News Coverage This Week

MarketBeat has tracked 21 news articles for Genpact this week, compared to 12 articles on an average week.

Search Interest

Only 23 people have searched for G on MarketBeat in the last 30 days. This is a decrease of -12% compared to the previous 30 days.

MarketBeat Follows

3 people have added Genpact to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Genpact insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $5,659,287.00 in company stock.

Percentage Held by Insiders

Only 3.07% of the stock of Genpact is held by insiders.

Percentage Held by Institutions

96.03% of the stock of Genpact is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

G Stock Analysis - Frequently Asked Questions

How have G shares performed this year?

Genpact's stock was trading at $42.95 at the beginning of the year. Since then, G shares have decreased by 3.1% and is now trading at $41.63.

How were Genpact's earnings last quarter?

Genpact Limited (NYSE:G) announced its earnings results on Thursday, August, 7th. The business services provider reported $0.88 EPS for the quarter, topping analysts' consensus estimates of $0.85 by $0.03. Genpact's quarterly revenue was up 6.6% on a year-over-year basis.
Read the conference call transcript.

Who are Genpact's major shareholders?

Top institutional investors of Genpact include State Street Corp (2.93%), Geode Capital Management LLC (2.08%), Franklin Resources Inc. (1.93%) and JPMorgan Chase & Co. (1.84%). Insiders that own company stock include Balkrishan Kalra, Piyush Mehta, Darren Saumur, Kathryn Vanpelt Stein, James C Madden, Heather White, Carol Lindstrom, Donald J Klunk, N V Tyagarajan and Nicholas C Gangestad.
View institutional ownership trends.

How do I buy shares of Genpact?

Shares of G stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Genpact own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Genpact investors own include Chevron (CVX), Comcast (CMCSA), Bristol Myers Squibb (BMY), Yum! Brands (YUM), McKesson (MCK), Edwards Lifesciences (EW) and Charles Schwab (SCHW).

Company Calendar

• Record date for 6/30 Dividend: 6/18/2025
• Ex-Dividend for 6/30 Dividend: 6/18/2025
• Dividend Payable: 6/30/2025
• Last Earnings: 8/07/2025
• Record date for 9/25 Dividend: 9/11/2025
• Ex-Dividend for 9/25 Dividend: 9/11/2025
• Today: 9/18/2025
• Dividend Payable: 9/25/2025
• Next Earnings (Estimated): 11/06/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Computer and Technology
• Industry: IT Services
• Sub-Industry: Data Processing & Outsourced Services
• Current Symbol: NYSE:G
• CIK: 1398659
• Web: www.genpact.com
• Phone: (441) 294-8000
• Fax: N/A
• Employees: 140,000
• Year Founded: 1997

Price Target and Rating

• Average Price Target for Genpact: $52.29
• High Price Target: $60.00
• Low Price Target: $47.00
• Potential Upside/Downside: +25.4%
• Consensus Rating: Hold
• Rating Score (0-4): 2.43
• Research Coverage: 7 Analysts

Profitability

• EPS (Trailing Twelve Months): $3.01
• Trailing P/E Ratio: 13.85
• Forward P/E Ratio: 12.99
• P/E Growth: 1.42
• Net Income: $513.67 million
• Net Margins: 10.92%
• Pretax Margin: 14.40%
• Return on Equity: 22.15%
• Return on Assets: 10.61%

Debt

• Debt-to-Equity Ratio: 0.32
• Current Ratio: 1.53
• Quick Ratio: 1.53

Sales & Book Value

• Annual Sales: $4.77 billion
• Price / Sales: 1.52
• Cash Flow: $3.63 per share
• Price / Cash Flow: 11.48
• Book Value: $13.55 per share
• Price / Book: 3.08

Miscellaneous

• Outstanding Shares: 174,270,000
• Free Float: 168,920,000
• Market Cap: $7.26 billion
• Optionable: Optionable
• Beta: 0.92